John E. Gerich, M.D.

John E. Gerich, M.D.

Contact Information


Office: (585) 275-2901
Fax: (585) 273-1288

Journal Articles

Showing all 52 journal articles available.

2010 Nov
Gerich J. "DPP-4 inhibitors: what may be the clinical differentiators?" Diabetes research and clinical practice. 2010 Nov; 90(2):131-40. Epub 2010 Aug 13.
2010 Mar 24
Aryangat AV, Gerich JE. "Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk." Vascular health and risk management. 2010 Mar 24; 6:145-55. Epub 2010 Mar 24.
2009 Sep
Samsom M, Bharucha A, Gerich JE, Herrmann K, Limmer J, Linke R, Maggs D, Schirra J, Vella A, Wörle HJ, Göke B. "Diabetes mellitus and gastric emptying: questions and issues in clinical practice." Diabetes/metabolism research and reviews. 2009 Sep; 25(6):502-14.
2009 Jul
Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L, . "Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)." Diabetes care. 2009 Jul; 32(7):1224-30. Epub 2009 Mar 16.
2009 Jun
King KB, Gerich JE, Guzick DS, King KU, McDermott MP. "Is a history of gestational diabetes related to risk factors for coronary heart disease?" Research in nursing & health. 2009 Jun; 32(3):298-306.
2009 May
Emerson P, Van Haeften TW, Pimenta W, Plummer E, Woerle HJ, Mitrakou A, Szoke E, Gerich J, Meyer C. "Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus." Metabolism: clinical and experimental. 2009 May; 58(5):602-7.
2008 May
Ceriello A, Colagiuri S, Gerich J, Tuomilehto J, . "Guideline for management of postmeal glucose." Nutrition, metabolism, and cardiovascular diseases : NMCD. 2008 May; 18(4):S17-33.
2008 Mar
Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C, Mitrakou A, Pimenta W, Gerich JE. "Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance." Diabetes care. 2008 Mar; 31(3):539-43. Epub 2007 Dec 14.
2008
Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich JE, Göke B, Schirra J. "Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide." Diabetes care. 2008 31(12):2325-31.
2007 Aug
Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B. "Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels." Diabetes research and clinical practice. 2007 Aug; 77(2):280-5. Epub 2007 Jan 22.
2007 Aug
Gerich JE, Odawara M, Terauchi Y. "The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk." Current medical research and opinion. 2007 Aug; 23(8):1791-8.
2007 May
Dunning BE, Gerich JE. "The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications." Endocrine reviews. 2007 May; 28(3):253-83. Epub 2007 Apr 04.
2007
Gerich JE. "Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors." Clinical cornerstone. 2007 8(3):53-68.
2007
Gadegbeku CA, Dhandayuthapani A, Taylor TP, Shrayyef Z, Gerich J, Garvey WT, Egan BM. "Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease." Journal of the American Society of Hypertension : JASH. 2007 1(6):414-22.
2006 Aug
Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J. "Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans." Diabetes care. 2006 Aug; 29(8):1909-14.
2006 May
Israelian Z, Szoke E, Woerle J, Bokhari S, Schorr M, Schwenke DC, Cryer PE, Gerich JE, Meyer C. "Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus." Metabolism: clinical and experimental. 2006 May; 55(5):593-8.
2006 Apr
Gerich J, Becker RH, Zhu R, Bolli GB. "Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine." Diabetes technology & therapeutics. 2006 Apr; 8(2):237-43.
2006 Jan
Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE. "Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes." American journal of physiology. Endocrinology and metabolism. 2006 Jan; 290(1):E67-E77. Epub 2005 Aug 16.
2006 Jan
Szoke E, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE. "Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia." Metabolism: clinical and experimental. 2006 Jan; 55(1):78-83.
2006
Gerich JE. "Postprandial hyperglycemia and cardiovascular disease." Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2006 12 Suppl 1:47-51.
2006
Gerich JE. "Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk." The Diabetes educator. 2006 32(4):513-4, 520-2.
2006
Gerich JE. "Glycemic control in the metabolic syndrome and implications in preventing cardiovascular disease." Metabolic syndrome and related disorders. 2006 4(4):315-27.
2005 Nov
Meyer C, Saar P, Soydan N, Eckhard M, Bretzel RG, Gerich J, Linn T. "A potential important role of skeletal muscle in human counterregulation of hypoglycemia." The Journal of clinical endocrinology and metabolism. 2005 Nov; 90(11):6244-50. Epub 2005 Sep 06.
2005 Nov
Israelian Z, Gosmanov NR, Szoke E, Schorr M, Bokhari S, Cryer PE, Gerich JE, Meyer C. "Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes." Diabetes care. 2005 Nov; 28(11):2691-6.
2005 Sep
Gerich J, Raskin P, Jean-Louis L, Purkayastha D, Baron MA. "PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin." Diabetes care. 2005 Sep; 28(9):2093-9.
2005 Sep
Gerich JE. "The importance of tight glycemic control." The American journal of medicine. 2005 Sep; 118(Suppl 9A):7S-11S.
2005 Jul
Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC, . "Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial." Diabetes care. 2005 Jul; 28(7):1630-5.
2005 May
Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C. "Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans." Diabetes care. 2005 May; 28(5):1124-31.
2005
Szoke E, Gerich JE. "Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus." Comprehensive therapy. 2005 31(2):106-12.
2004 Sep
Meyer C, Woerle HJ, Gerich J. "Paradoxical changes of muscle glutamine release during hyperinsulinemia euglycemia and hypoglycemia in humans: further evidence for the glucose-glutamine cycle." Metabolism: clinical and experimental. 2004 Sep; 53(9):1208-14.
2004 Aug 26
Gerich JE, Dailey G. "Advances in diabetes for the millennium: understanding insulin resistance." MedGenMed : Medscape general medicine. 2004 Aug 26; 6(3 Suppl):11. Epub 2004 Aug 26.
2004 Jan
Gerich JE. "Insulin glargine: long-acting basal insulin analog for improved metabolic control." Current medical research and opinion. 2004 Jan; 20(1):31-7.
2004
Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE. "Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values." Archives of internal medicine. 2004 164(15):1627-32.
2004
Meyer C, Woerle HJ, Dostou JM, Welle SL, Gerich JE. "Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes." American journal of physiology. Endocrinology and metabolism. 2004 287(6):E1049-56. Epub 2004 Aug 10.
2003 Nov
Riddle MC, Rosenstock J, Gerich J, . "The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients." Diabetes care. 2003 Nov; 26(11):3080-6.
2003 Oct
Meyer C, Stumvoll M, Welle S, Woerle HJ, Haymond M, Gerich J. "Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans." American journal of physiology. Endocrinology and metabolism. 2003 Oct; 285(4):E819-26.
2003 Jun 9
Gerich JE. "Clinical significance, pathogenesis, and management of postprandial hyperglycemia." Archives of internal medicine. 2003 Jun 9; 163(11):1306-16.
2003 Jun
Woerle HJ, Meyer C, Popa EM, Cryer PE, Gerich JE. "Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity." Diabetes. 2003 Jun; 52(6):1386-92.
2003 Apr
Woerle HJ, Meyer C, Dostou JM, Gosmanov NR, Islam N, Popa E, Wittlin SD, Welle SL, Gerich JE. "Pathways for glucose disposal after meal ingestion in humans." American journal of physiology. Endocrinology and metabolism. 2003 Apr; 284(4):E716-25. Epub 2002 Dec 10.
2003 Apr
Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, Welle SL, Gerich JE. "Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens." Diabetes. 2003 Apr; 52(4):918-25.
2003 Apr
Gerich JE. "Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus." Mayo Clinic proceedings. 2003 Apr; 78(4):447-56.
2002 Nov
Woerle HJ, Popa E, Dostou J, Welle S, Gerich J, Meyer C. "Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance." Metabolism: clinical and experimental. 2002 Nov; 51(11):1494-500.
2002 Sep
Korytkowski M, Thomas A, Reid L, Tedesco MB, Gooding WE, Gerich J. "Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes." Diabetes care. 2002 Sep; 25(9):1607-11.
2002 Sep
Toft I, Gerich JE, Jenssen T. "Autoregulation of endogenous glucose production during hyperglucagonemia." Metabolism: clinical and experimental. 2002 Sep; 51(9):1128-34.
2002 Sep
Gerich JE. "Novel insulins: expanding options in diabetes management." The American journal of medicine. 2002 Sep; 113(4):308-16.
2002 Jun
Meyer C, Gerich JE. "Role of the kidney in hyperglycemia in type 2 diabetes." Current diabetes reports. 2002 Jun; 2(3):237-41.
2002 Feb
Meyer C, Dostou JM, Welle SL, Gerich JE. "Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis." American journal of physiology. Endocrinology and metabolism. 2002 Feb; 282(2):E419-27.
2002 Feb
Meyer C, Stumvoll M, Dostou J, Welle S, Haymond M, Gerich J. "Renal substrate exchange and gluconeogenesis in normal postabsorptive humans." American journal of physiology. Endocrinology and metabolism. 2002 Feb; 282(2):E428-34.
2002 Feb
Gerich JE. "Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?" Diabetes. 2002 Feb; 51 Suppl 1:S117-21.
2002 Feb
van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE. "Disturbances in beta-cell function in impaired fasting glycemia." Diabetes. 2002 Feb; 51 Suppl 1:S265-70.
1997 Apr
Kreider ME, Stumvoll M, Meyer C, Overkamp D, Welle S, Gerich J. "Steady-state and non-steady-state measurements of plasma glutamine turnover in humans." The American journal of physiology. 1997 Apr; 272(4 Pt 1):E621-7.
1990 Apr
Campbell PJ, Gerich JE. "Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity." The Journal of clinical endocrinology and metabolism. 1990 Apr; 70(4):1114-8.